The role of Shenqi Fuzheng injection as adjuvant therapy for breast cancer: an overview of systematic reviews and meta-analyses
Abstract Background Breast cancer (BC) is the most frequent malignancy in the world. Chemotherapy (CT) is a common treatment for BC but is accompanied by toxicity and side effects. Shenqi Fuzheng Injection (SFI) is an adjuvant therapy with promising results in improving efficacy and reducing toxicit...
| Published in: | BMC Complementary Medicine and Therapies |
|---|---|
| Main Authors: | Jing Xu, Xiao Li, Liyuan Lv, Qing Dong, Xiaofeng Du, Guangda Li, Li Hou |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-01-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12906-023-04274-4 |
Similar Items
Systematic review and meta-analysis of shenqi fuzheng and chemotherapy combination in the treatment of breast cancer
by: Ying Li, et al.
Published: (2016-10-01)
by: Ying Li, et al.
Published: (2016-10-01)
Shenqi Fuzheng injection hinders non-small cell lung cancer cell growth by regulating the Bax/Bcl-2 signaling pathway
by: Siqi Li, et al.
Published: (2024-05-01)
by: Siqi Li, et al.
Published: (2024-05-01)
Shenqi Fuzheng Injection Reduces Cisplatin-Induced Kidney Injury via cGAS/STING Signaling Pathway in Breast Cancer Mice Model
by: Ma Y, et al.
Published: (2024-08-01)
by: Ma Y, et al.
Published: (2024-08-01)
Predicting Adsorption Performance Based on the Properties of Activated Carbon: A Case Study of Shenqi Fuzheng System
by: Zhilong Tang, et al.
Published: (2025-08-01)
by: Zhilong Tang, et al.
Published: (2025-08-01)
Effectiveness and safety of Shenqi Fuzheng injection combined with platinum-based chemotherapy for treatment of advanced non-small cell lung cancer: a systematic review and meta-analysis
by: Chenxi Qiao, et al.
Published: (2023-08-01)
by: Chenxi Qiao, et al.
Published: (2023-08-01)
Cost-effectiveness of Kang Ai injection plus chemotherapy vs. Shenqi Fuzheng injection plus chemotherapy in the first-line treatment of advanced non-small cell lung cancer
by: Junjie Zhu, et al.
Published: (2024-05-01)
by: Junjie Zhu, et al.
Published: (2024-05-01)
Authentication of Shenqi Fuzheng Injection via UPLC-Coupled Ion Mobility—Mass Spectrometry and Chemometrics with Kendrick Mass Defect Filter Data Mining
by: Xingdong Wu, et al.
Published: (2022-07-01)
by: Xingdong Wu, et al.
Published: (2022-07-01)
Estudio clínico de penetración direccional de decocción Shenqi Fuzheng para el tratamiento del dolor por cáncer en pacientes con cáncer de pulmón avanzado
by: Shuang Wu, et al.
Published: (2025-01-01)
by: Shuang Wu, et al.
Published: (2025-01-01)
Shenqi Fuzheng Injection Combined With Chemotherapy for Gastric Cancer: An Overview of Systematic Reviews and Meta-Analyses
by: Jing Xu MD, PhD, et al.
Published: (2023-11-01)
by: Jing Xu MD, PhD, et al.
Published: (2023-11-01)
Effect of Shenqi Dihuang Decoction plus benazepril on diabetic kidney disease
by: Chan-juan Nie, et al.
Published: (2024-12-01)
by: Chan-juan Nie, et al.
Published: (2024-12-01)
Shenqi Sanjie Granules induce Hmox1-mediated ferroptosis to inhibit colorectal cancer
by: Meng Chen, et al.
Published: (2024-09-01)
by: Meng Chen, et al.
Published: (2024-09-01)
Fuzheng Jiedu granules against disease progression among high-risk adults with non-severe COVID-19: a multicenter retrospective cohort study
by: Qiaoli Hua, et al.
Published: (2025-05-01)
by: Qiaoli Hua, et al.
Published: (2025-05-01)
Chinese herbal medicine Shenqi compound for early intervention in patients at high cardiovascular risk of type 2 diabetes mellitus: the protocol of a multicenter, randomized, double-blind, placebo-controlled trial
by: Yulin Leng, et al.
Published: (2024-01-01)
by: Yulin Leng, et al.
Published: (2024-01-01)
Syndrome of liver depression and spleen deficiency is a primary TCM syndrome of response to entecavir + FuZheng HuaYu in patients with HBV-related liver fibrosis
by: Yun-kai Dai, et al.
Published: (2023-11-01)
by: Yun-kai Dai, et al.
Published: (2023-11-01)
Qingjie Fuzheng granules treat ulcerative colitis by regulating Th17/Treg balance
by: Hangyan Zhong, et al.
Published: (2024-06-01)
by: Hangyan Zhong, et al.
Published: (2024-06-01)
Toxicity studies of condensed fuzheng extract in mice and rats
by: JiDa Wang, et al.
Published: (2024-02-01)
by: JiDa Wang, et al.
Published: (2024-02-01)
Mechanism of Fuzheng Qudu prescription in the treatment of lung cancer based on network pharmacology and experimental validation
by: Binjie Su, et al.
Published: (2024-09-01)
by: Binjie Su, et al.
Published: (2024-09-01)
Effect of Qingjie Fuzheng Granules on Proliferation, Apoptosis and Migration of Colorectal Cancer SW620 Cells
by: Xiaoqin ZHU, et al.
Published: (2020-02-01)
by: Xiaoqin ZHU, et al.
Published: (2020-02-01)
Chinese Herbal Medicine Xingnaojing Injection for Acute Ischemic Stroke: An Overview of Systematic Reviews and Meta-Analyses
by: Zi-Yu Tian, et al.
Published: (2021-05-01)
by: Zi-Yu Tian, et al.
Published: (2021-05-01)
Systematic Evaluation of Clinical Efficacy of Shiyiwei Shenqi (Ginseng and Astraglus, Eleven Ingredients) Preparation in Adjuvant Chemotherapy for Malignant Tumor
by: Bowei HUANG, et al.
Published: (2021-04-01)
by: Bowei HUANG, et al.
Published: (2021-04-01)
Investigation of the hypoglycemic mechanism of the ShenQi compound formula through metabonomics and 16S rRNA sequencing
by: Juan Gao, et al.
Published: (2024-04-01)
by: Juan Gao, et al.
Published: (2024-04-01)
Effect of Jingui Shenqi Pill on the Differential Proteins in Femoral Cortical Bone of Kidney-yang Deficiency Rats Model
by: Naixi ZHENG, et al.
Published: (2017-02-01)
by: Naixi ZHENG, et al.
Published: (2017-02-01)
Efficacy and mechanism of Shenqi Compound in inhibiting diabetic vascular calcification
by: Chan Yang, et al.
Published: (2023-12-01)
by: Chan Yang, et al.
Published: (2023-12-01)
Benefit-risk evaluation of Fuzheng Yiliu Decoction combined with chemotherapy for treating non-small cell lung cancer using multicriteria decision analysis
by: Dongjing Ma, et al.
Published: (2025-09-01)
by: Dongjing Ma, et al.
Published: (2025-09-01)
Effect of Fuzheng Jiedu granule on immunological function and level of immune-related cytokines in immune-suppressed mice
by: Zhan-mei YU, et al.
Published: (2016-03-01)
by: Zhan-mei YU, et al.
Published: (2016-03-01)
FoxO1 as a Hub in Immunosenescence Induced by Hepatocellular Carcinoma and the Effect of Yangyin Fuzheng Jiedu Prescription
by: Xie Y, et al.
Published: (2025-03-01)
by: Xie Y, et al.
Published: (2025-03-01)
Yiai Fuzheng decoction inhibits triple-negative breast cancer by remodeling the immune microenvironment
by: Chaochao Yu, et al.
Published: (2025-09-01)
by: Chaochao Yu, et al.
Published: (2025-09-01)
The Adjunctive Efficacy of Fuzheng Huayu Tablet on Portal Hypertension with HBV Related Cirrhosis: A Protocol for a Multicenter Randomized Controlled Trial
by: Li Z, et al.
Published: (2025-06-01)
by: Li Z, et al.
Published: (2025-06-01)
Elucidating the Differential Mechanisms of Jingui Shenqi Pill and Mingmu Dihuang Pill in the Treatment of Diabetic Nephropathy Based on Yin-Yang Theory
by: Bi S, et al.
Published: (2025-04-01)
by: Bi S, et al.
Published: (2025-04-01)
Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma
by: Yuqing Xie, et al.
Published: (2023-02-01)
by: Yuqing Xie, et al.
Published: (2023-02-01)
Study on the preparation process and quality standard of Ji Shenqi anti-cancer granules
by: LI Liang, et al.
Published: (2025-02-01)
by: LI Liang, et al.
Published: (2025-02-01)
Homotherapy for heteropathy of chronic kidney disease and oligoasthenozoospermia through regulating SIRT1/NF-κB pathway by Shenqi pills
by: Shuo Huang, et al.
Published: (2025-06-01)
by: Shuo Huang, et al.
Published: (2025-06-01)
The effects of Shenqi Jiangtang granule combined with Western medicine on glucose and lipid metabolism in women with gestational diabetes mellitus
by: Xiaoqiang Hu, et al.
Published: (2022-12-01)
by: Xiaoqiang Hu, et al.
Published: (2022-12-01)
A multi-center, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of Fuzheng Yangxin Granule in treating heart failure with preserved ejection fraction (Qi-Yin deficiency and blood stasis syndrome): study protocol
by: Jingjing Chen, et al.
Published: (2025-04-01)
by: Jingjing Chen, et al.
Published: (2025-04-01)
Jiedu Fuzheng decoction improves the proliferation, migration, invasion and EMT of non-small cell lung cancer via the Wnt/β-catenin pathway
by: Fang Fang, et al.
Published: (2023-12-01)
by: Fang Fang, et al.
Published: (2023-12-01)
Therapeutic Effect and Mechanism of the Fuzheng Buxue Recipe in Rats with Chemotherapy-Induced Myelosuppression
by: Min Yang, et al.
Published: (2025-07-01)
by: Min Yang, et al.
Published: (2025-07-01)
Shenqi Fuzheng injection alleviates chemotherapy-induced cachexia by restoring glucocorticoid signaling in hypothalamus
by: Entezar Berik, et al.
Published: (2024-03-01)
by: Entezar Berik, et al.
Published: (2024-03-01)
Investigating the cardioprotective effects of Fuzheng Yangxin recipe based on network pharmacology and experimental evaluation
by: Anzhu Wang, et al.
Published: (2022-09-01)
by: Anzhu Wang, et al.
Published: (2022-09-01)
Knockdown and Overexpression Experiments to Investigate the Inhibitory Mechanism of Fuzheng Xiaozheng Prescription, an Effective Chinese Herbal Formula for the Clinical Treatment of Hepatocellular Carcinoma
by: Xia Li, et al.
Published: (2024-08-01)
by: Xia Li, et al.
Published: (2024-08-01)
Jinkui Shenqi Pill Combined with Pelvic Floor Biofeedback in Treatment of Postpartum Stress Urinary Incontinence with Kidney-yang Deficiency
by: Xueqin MIAO, et al.
Published: (2021-06-01)
by: Xueqin MIAO, et al.
Published: (2021-06-01)
Similar Items
-
Systematic review and meta-analysis of shenqi fuzheng and chemotherapy combination in the treatment of breast cancer
by: Ying Li, et al.
Published: (2016-10-01) -
Shenqi Fuzheng injection hinders non-small cell lung cancer cell growth by regulating the Bax/Bcl-2 signaling pathway
by: Siqi Li, et al.
Published: (2024-05-01) -
Shenqi Fuzheng Injection Reduces Cisplatin-Induced Kidney Injury via cGAS/STING Signaling Pathway in Breast Cancer Mice Model
by: Ma Y, et al.
Published: (2024-08-01) -
Predicting Adsorption Performance Based on the Properties of Activated Carbon: A Case Study of Shenqi Fuzheng System
by: Zhilong Tang, et al.
Published: (2025-08-01) -
Effectiveness and safety of Shenqi Fuzheng injection combined with platinum-based chemotherapy for treatment of advanced non-small cell lung cancer: a systematic review and meta-analysis
by: Chenxi Qiao, et al.
Published: (2023-08-01)
